REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Magnolia Pharm Sp. z o.o. (Poland)

Main Activities: Department Stores
Secondary Activities: Pharmaceutical Preparation Manufacturing | All Other Specialty Food Stores | Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores | Rental and Leasing Services | Other Personal and Household Goods Repair and Maintenance | Other Personal Care Services
Full name: Magnolia Pharm Sp. z o.o. Profile Updated: November 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Magnolia Pharm Sp. z o.o. is based in Poland, with the head office in Marki. The enterprise currently operates in the Department Stores sector. The company was established on October 11, 2012. The total number of employees is currently 6 - 20 (2014). From the latest financial highlights, Magnolia Pharm Sp. z o.o. reported a net sales revenue increase of 12.84% in 2023. Its’ total assets recorded a growth of 20.42%. In 2023, Magnolia Pharm Sp. z o.o.’s net profit margin increased by 4.71%.

Headquarters
Ul. Batalionow Chlopskich 27
Marki; Mazowieckie; Postal Code: 05-270

Contact Details: Purchase the Magnolia Pharm Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Magnolia Pharm Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Magnolia Pharm Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Magnolia Pharm Sp. z o.o. report to view the information.
Incorporation Date:
October 11, 2012
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
4.67%
Company Performance
Financial values in the chart are available after Magnolia Pharm Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
12.84%▲
Total operating revenue
7.18%▲
Operating profit (EBIT)
464.32%▲
EBITDA
328.3%▲
Net Profit (Loss) for the Period
409.04%▲
Total assets
20.42%▲
Total equity
21.84%▲
Operating Profit Margin (ROS)
5.43%▲
Net Profit Margin
4.71%▲
Return on Equity (ROE)
13.63%▲
Debt to Equity Ratio
-0.57%▼
Quick Ratio
0.1%▲
Cash Ratio
0.19%▲

Similar companies

Adamed Pharma S.A.
 
"Przedsiebiorstwo Produkcji Farmaceutycznej Hasco - Lek" S.A.
Ziaja Ltd Zaklad Produkcji Lekow Sp. z o.o.
 
Maco Productions Polonia Sp. z o.o.
Gedeon Richter Polska Sp. z o.o.
 
Tarchominskie Zaklady Farmaceutyczne "Polfa" S.A.
Nellex Polska Sp. z o.o.
 
"J.J.B. Omega" Sp. z o.o.
Akademia Boreliozy Sp. z o.o.
 
Avitaris Sp. z o.o.
Beneton Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo